{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:09:05Z","timestamp":1789790945175,"version":"4.0.1"},"reference-count":60,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Photodynamic therapy (PDT) has become a widely used modality for treating actinic keratosis (AK) and non-melanoma skin cancers (NMSC), as well as other inflammatory or infectious diseases. Despite its efficacy, limitations such as incomplete responses and pain have motivated the exploration of protocol enhancements. This review examines the clinical and biological rationale for light fractionation\u2014dividing the total light dose into two separate exposures with a dark interval\u2014as a strategy to improve PDT outcomes. We reviewed preclinical and clinical studies evaluating fractionated illumination using 5-aminolevulinic acid (ALA) or methyl aminolevulinate (MAL). The findings consistently demonstrate superior efficacy of fractionated schemes, particularly with ALA, showing higher complete response rates in AK, superficial basal cell carcinoma (sBCC), and Bowen\u2019s disease (BD), and improved long-term tumor control compared to single illumination. The better outcomes are attributed to increased reactive oxygen species (ROS) generation following tissue reoxygenation during the dark interval and greater susceptibility of partially damaged cells to subsequent illumination. Fractionated PDT also shows a favorable safety and cosmetic profile. These results support considering light fractionation protocols as a standard approach for optimizing PDT efficacy in dermatologic oncology, particularly in lesions with limited depth and high recurrence risk.<\/jats:p>","DOI":"10.3390\/ijms26168054","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:02:44Z","timestamp":1755763364000},"page":"8054","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimization of Photodynamic Therapy in Dermatology: The Role of Light Fractionation"],"prefix":"10.3390","volume":"26","author":[{"given":"Luis","family":"Alonso-Mtz de Salinas","sequence":"first","affiliation":[{"name":"Dermatology Department, Hospital Universitario Ramon y Cajal, Carretera M-607 km 9.1, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-8361","authenticated-orcid":false,"given":"Emilio","family":"Garcia-Mouronte","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Ramon y Cajal, Carretera M-607 km 9.1, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-9032","authenticated-orcid":false,"given":"Jorge","family":"Naharro-Rodriguez","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Ramon y Cajal, Carretera M-607 km 9.1, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7123-9869","authenticated-orcid":false,"given":"Luis Alfonso","family":"Perez-Gonzalez","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Ramon y Cajal, Carretera M-607 km 9.1, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Fern\u00e1ndez-Guarino","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Ramon y Cajal, Carretera M-607 km 9.1, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1578-2190(07)70471-7","article-title":"Photodynamic Therapy: New Indications","volume":"98","author":"Harto","year":"2007","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (Engl. Ed.)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: Treatment delivery and established indications\u2014Actinic keratoses, Bowen\u2019s disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104099","DOI":"10.1016\/j.drudis.2024.104099","article-title":"The dual role of photodynamic therapy to treat cancer and microbial infection","volume":"29","author":"Akhtar","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy\u2014Mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2005.10.019","article-title":"Mechanisms involved in \u03b4-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin","volume":"71","author":"Ohgari","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"De Bruijn, H.S., Brooks, S., Van Der Ploeg-Van Den Heuvel, A., Ten Hagen, T.L.M., De Haas, E.R.M., and Robinson, D.J. (2016). Light fractionation significantly increases the efficacy of photodynamic therapy using BF-200 ALA in normal mouse skin. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148850"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ad.2015.06.001","article-title":"Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis","volume":"106","author":"Gilaberte","year":"2015","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garcia-Mouronte, E., Naharro-Rodriguez, J., Alonso-Mtz de Salinas, L., P\u00e9rez-Gonz\u00e1lez, L.A., and Fern\u00e1ndez-Guarino, M. (2025). Self-Applied Daylight Photodynamic Therapy: A Paradigm Shift?. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020628"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Algorri, J.F., L\u00f3pez-Higuera, J.M., Rodr\u00edguez-Cobo, L., and Cobo, A. (2023). Advanced Light Source Technologies for Photodynamic Therapy of Skin Cancer Lesions. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082075"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2009.04.001","article-title":"Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT","volume":"96","author":"Robertson","year":"2009","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/bjc.1996.310","article-title":"Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX","volume":"74","author":"Noodt","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_12","first-page":"1324","article-title":"The Two Faces of Fractionated Photodynamic Therapy: Increasing Efficacy With Light Fractionation or Adjuvant Use of Fractional Laser Technology","volume":"15","author":"Juhasz","year":"2016","journal-title":"J. Drugs Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.jid.5700460","article-title":"Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy","volume":"126","author":"Kruijt","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hong, L., Li, J., Luo, Y., Guo, T., Zhang, C., Ou, S., Long, Y., and Hu, Z. (2022). Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy. Biomolecules, 12.","DOI":"10.3390\/biom12010081"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1468-3083.2007.02445.x","article-title":"Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer","volume":"22","author":"Sterenborg","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2011.04003.x","article-title":"Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: A randomized, intraindividual comparison trial with 12-month follow-up","volume":"26","author":"Sotiriou","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_17","first-page":"67","article-title":"Fractionated Illumination Improves the Outcome in the Treatment of Precancerous Lesions with Photodynamic Therapy","volume":"32","author":"Zorc","year":"2008","journal-title":"Coll. Antropol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.15967","article-title":"Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: Results of a randomized controlled trial","volume":"178","author":"Kessels","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13246-011-0064-6","article-title":"Simulation of fractionated and continuous irradiation in photodynamic therapy: Study the differences between photobleaching and singlet oxygen dose deposition","volume":"34","author":"Naghavi","year":"2011","journal-title":"Australas. Phys. Eng. Sci. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/bjc.2016.267","article-title":"Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer","volume":"115","author":"Marra","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_21","first-page":"35","article-title":"Reactive oxygen species explicit dosimetry (ROSED) for fractionated photofrin-mediated photodynamic therapy (PDT)","volume":"11940","author":"Sun","year":"2022","journal-title":"Proc. SPIE Int. Soc. Opt. Eng."},{"key":"ref_22","first-page":"33","article-title":"Evaluation of fractionated PHOTOFRIN-mediated photodynamic therapy using different light fluences with Reactive Oxygen Species Explicit Dosimetry (ROSED)","volume":"12359","author":"Sun","year":"2023","journal-title":"Proc. SPIE Int. Soc. Opt. Eng."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sun, H., Yang, W., Ong, Y., Busch, T.M., and Zhu, T.C. (2023). Fractionated Photofrin-Mediated Photodynamic Therapy Significantly Improves Long-Term Survival. Cancers, 15.","DOI":"10.3390\/cancers15235682"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1039\/b708340h","article-title":"Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin","volume":"6","author":"Hebeda","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1011-1344(02)00410-4","article-title":"Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells","volume":"69","author":"Smetana","year":"2003","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1039\/c2pp25287b","article-title":"Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; The influence of PpIX concentration and illumination parameters","volume":"12","author":"Casas","year":"2013","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Robinson, D.J., de Bruijn, H.S., Star, W.M., and Sterenborg, H.J.C.M. (2003). Dose and Timing of the First Light Fraction in Two-fold Illumination Schemes for Topical ALA-mediated Photodynamic Therapy of Hairless Mouse Skin. Photochem. Photobiol., 77.","DOI":"10.1562\/0031-8655(2003)077<0319:DATOTF>2.0.CO;2"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-0129","article-title":"Topical 5-aminolaevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: Long-term follow-up","volume":"86","author":"Star","year":"2006","journal-title":"Acta. Derm. Venereol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1021\/acsbiomaterials.1c00690","article-title":"In Vitro Low-Fluence Photodynamic Therapy Parameter Screening Using 3D Tumor Spheroids Shows that Fractionated Light Treatments Enhance Phototoxicity","volume":"7","author":"Gagui","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/php.12271","article-title":"Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin","volume":"90","author":"Middelburg","year":"2014","journal-title":"Photochem. Photobiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/bjc.1994.412","article-title":"In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: Increased damage after multiple irradiations","volume":"70","author":"Star","year":"1994","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-1448","article-title":"Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: Five-year follow-up of a randomized, prospective trial","volume":"92","author":"Sterenborg","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1159\/000524745","article-title":"Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma","volume":"238","author":"Nelemans","year":"2022","journal-title":"Dermatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: A randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: Results of a randomized controlled trial","volume":"159","author":"Mosterd","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_36","first-page":"264","article-title":"Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme","volume":"143","author":"Sterenborg","year":"2007","journal-title":"Arch. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1684\/ejd.2015.2648","article-title":"Treatment of actinic cheilitis with methyl aminolevulinate photodynamic therapy and light fractionation: A prospective study of 10 patients","volume":"25","author":"Aguilera","year":"2015","journal-title":"Eur. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.2006.07290.x","article-title":"A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis","volume":"155","author":"Smits","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101622","DOI":"10.1016\/j.pdpdt.2019.101622","article-title":"Fractionated illumination improves the treatment outcomes of photodynamic therapy for high grade cutaneous leishmaniasis","volume":"29","author":"Khan","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/bjd.17350","article-title":"Photodynamic therapy for actinic keratosis of the forehead and scalp: A randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp","volume":"180","author":"Vicentini","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pdpdt.2019.04.016","article-title":"Single visit PDT for basal cell carcinoma\u2014A new therapeutic protocol","volume":"26","author":"Ramirez","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102668","DOI":"10.1016\/j.pdpdt.2021.102668","article-title":"A new photodynamic therapy protocol for nodular basal cell carcinoma treatment: Effectiveness and long-term follow-up","volume":"37","author":"Salvio","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1751-1097.2005.tb00233.x","article-title":"Photodynamic Treatment with Fractionated Light Decreases Production of Reactive Oxygen Species and Cytotoxicity in vitro via Regeneration of Glutathione","volume":"81","author":"Oberdanner","year":"2005","journal-title":"Photochem. Photobiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/anie.201511345","article-title":"A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light","volume":"55","author":"Turan","year":"2016","journal-title":"Angew. Chem.\u2014Int. Ed."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2103627","DOI":"10.1002\/adma.202103627","article-title":"Singlet Oxygen \u201cAfterglow\u201d Therapy with NIR-II Fluorescent Molecules","volume":"33","author":"Zou","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1039\/C7TB00950J","article-title":"Persistent luminescent nanoparticles as energy mediators for enhanced photodynamic therapy with fractionated irradiation","volume":"5","author":"Wang","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.apsb.2021.03.017","article-title":"Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kan, D., Ding, R., Yang, H., Jia, Y., Lei, K., Wang, Z., Zhang, W., Yang, C., Liu, Z., and Xie, F. (2025). Synergistic strategies in photodynamic combination therapy for cancer: Mechanisms, nanotechnology, and clinical translation. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1607259"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"adv6579","DOI":"10.2340\/actadv.v103.6579","article-title":"Ablative Fractional Laser Enhances Artificial or Natural Daylight Photodynamic Therapy of Actinic Field Cancerization: A Randomized and Investigator-initiated Half-side Comparative Study","volume":"103","author":"Lindholm","year":"2023","journal-title":"Acta Derm.-Venereol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1039\/D4TB00483C","article-title":"Advances and perspectives in phototherapy-based combination therapy for cancer treatment","volume":"12","author":"Yi","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bjd.16838","article-title":"Conventional and combination topical photodynamic therapy for basal cell carcinoma: Systematic review and meta-analysis","volume":"179","author":"Collier","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103700","DOI":"10.1016\/j.pdpdt.2023.103700","article-title":"Efficacy and safety of microneedling, fractional CO2 laser, and cryotherapy combined with 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis: A multicenter prospective randomized controlled study","volume":"43","author":"Qiao","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104463","DOI":"10.1016\/j.pdpdt.2024.104463","article-title":"Ferroptosis: A novel cell death modality as a synergistic therapeutic strategy with photodynamic therapy","volume":"51","author":"Wang","year":"2025","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1039\/D0NR08757B","article-title":"Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment","volume":"13","author":"Chen","year":"2021","journal-title":"Nanoscale"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"216839","DOI":"10.1016\/j.ccr.2025.216839","article-title":"Small molecule photosensitizers: Paving the way for improved photodynamic therapy in dermatology","volume":"541","author":"Wu","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"21915","DOI":"10.1039\/D4RA02564D","article-title":"Unveiling the potential of photodynamic therapy with nanocarriers as a compelling therapeutic approach for skin cancer treatment: Current explorations and insights","volume":"14","author":"Mohanty","year":"2024","journal-title":"RSC Adv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1039\/D3SC07006A","article-title":"Recent advances for enhanced photodynamic therapy: From new mechanisms to innovative strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Chem. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/en.2017-03230","article-title":"How UV Light Touches the Brain and Endocrine System Through Skin, and Why","volume":"159","author":"Slominski","year":"2018","journal-title":"Endocrinology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2308374121","DOI":"10.1073\/pnas.2308374121","article-title":"Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system","volume":"121","author":"Slominski","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41574-025-01107-x","article-title":"Neuro-immuno-endocrinology of the skin: How environment regulates body homeostasis","volume":"21","author":"Slominski","year":"2025","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/8054\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:07Z","timestamp":1760034727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/8054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":60,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26168054"],"URL":"https:\/\/doi.org\/10.3390\/ijms26168054","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}